Pharmacology

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

Dr. Andrés Rodríguez - 8 June, 2026 0

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Dr. Omar Tupayachi - 5 June, 2026 0

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Dr. Juan Manuel Pérez - 4 June, 2026 0

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Institutional News

Watch Again: Clinical Implications of Structural Heart Interventions — TAVI and MitraClip in Daily Practice

solaci - 4 June, 2026 0

The recording of the webinar “Structural Interventions: TAVI and MitraClip in Daily Practice” is now available on the SOLACI YouTube channel. The activity was...

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

solaci - 2 June, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

Open Session | Current Endovascular Treatment of Tricuspid Regurgitation

solaci - 1 June, 2026 0

SOLACI and the Argentine College of Interventional Cardioangiologists (CACI) invite you to participate in a new Open Session of the Advanced Postgraduate Course in...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy

Promising Outcomes of Overlapping Stents in Patients Undergoing Bioresorbable Scaffold (BRS) Implantation

Dual antiaggregation time and death by bleeding

Peripheral artery disease associated to ischemic and bleeding events after DES implantation

Catheter-directed thrombolysis for pulmonary embolism: a safe technique

Aspirin Desensitization in Patients with Coronary Artery Disease

Apixaban: An Alternative for Patients with Atrial Fibrillation Undergoing TAVR?

Ticagrelor Versus Clopidogrel in Symptomatic Peripheral Vascular Disease

Anticoagulated Patients with Atrial Fibrillation Undergoing Angioplasty: How to Treat Them